S&P 500   2,969.36 (-0.03%)
DOW   26,840.35 (+0.09%)
QQQ   191.39 (+0.15%)
AAPL   237.63 (+0.60%)
FB   183.81 (-0.21%)
MSFT   139.98 (+0.21%)
GOOGL   1,222.40 (+0.55%)
AMZN   1,727.72 (-0.24%)
GE   8.73 (-0.80%)
TSLA   254.88 (+2.82%)
AMD   29.80 (+0.17%)
T   37.42 (-0.43%)
F   8.81 (+0.34%)
PRI   121.28 (-0.34%)
BAC   29.11 (+0.69%)
GILD   64.68 (+1.08%)
DIS   129.88 (-0.12%)
S&P 500   2,969.36 (-0.03%)
DOW   26,840.35 (+0.09%)
QQQ   191.39 (+0.15%)
AAPL   237.63 (+0.60%)
FB   183.81 (-0.21%)
MSFT   139.98 (+0.21%)
GOOGL   1,222.40 (+0.55%)
AMZN   1,727.72 (-0.24%)
GE   8.73 (-0.80%)
TSLA   254.88 (+2.82%)
AMD   29.80 (+0.17%)
T   37.42 (-0.43%)
F   8.81 (+0.34%)
PRI   121.28 (-0.34%)
BAC   29.11 (+0.69%)
GILD   64.68 (+1.08%)
DIS   129.88 (-0.12%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 MesoblastGENFIT S A/ADRVoyager TherapeuticsOsiris TherapeuticsVericel
SymbolNASDAQ:MESONASDAQ:GNFTNASDAQ:VYGRN/ANASDAQ:VCEL
Price Information
Current Price$6.23$14.60$14.97N/A$14.25
52 Week RangeBuyBuyBuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$12.40$52.62$28.86N/A$23.23
% Upside from Price Target99.04% upside260.39% upside92.77% upsideN/A63.02% upside
Trade Information
Market Cap$625.07 million$517.18 million$555.43 million$655.69 million$631.64 million
Beta1.78N/A2.61N/A2.66
Average Volume55,01626,394468,203202,293547,339
Sales & Book Value
Annual Revenue$16.72 million$8.85 million$7.62 millionN/A$90.86 million
Price / Sales37.1662.4172.55N/A6.92
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$4.82 per shareN/A$1.43 per shareN/A$2.36 per share
Price / Book1.2910.47N/A6.04
Profitability
Net Income$-89,800,000.00$-93,910,000.00$-88,290,000.00N/A$-8,140,000.00
EPS($0.91)N/A($2.75)N/A($0.14)
Trailing P/E RatioN/A0.00N/A0.00N/A
Forward P/E RatioN/AN/AN/AN/A50.89
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-536.97%N/A-106.23%N/A-18.14%
Return on Equity (ROE)-17.66%N/A-71.08%N/A-0.99%
Return on Assets (ROA)-13.28%N/A-20.05%N/A-0.75%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.14%1.85%N/AN/A0.28%
Current Ratio1.41%6.45%4.93%N/A7.50%
Quick Ratio1.41%6.44%4.93%N/A7.12%
Ownership Information
Institutional Ownership Percentage2.60%10.19%78.49%0.28%88.74%
Insider Ownership Percentage18.80%N/A22.90%43.40%4.50%
Miscellaneous
Employees81148123N/A216
Shares Outstanding99.73 million37.83 million36.93 million34.53 million44.14 million
Next Earnings Date11/21/2019 (Estimated)N/A11/6/2019 (Estimated)N/A11/5/2019 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable
 MesoblastGENFIT S A/ADRVoyager TherapeuticsOsiris TherapeuticsVericel

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel